247 related articles for article (PubMed ID: 8392757)
1. Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain.
Fitzgerald LW; Teitler M
Synapse; 1993 Jun; 14(2):154-9. PubMed ID: 8392757
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
3. Stereochemical requirements for pseudoirreversible inhibition of opioid mu receptor binding by the 3-methylfentanyl congeners, RTI-46144 and its enantiomers: evidence for different binding domains.
Ni Q; Xu H; Partilla JS; Stark PA; Carroll FI; Brine GA; Rothman RB
Synapse; 1993 Dec; 15(4):296-306. PubMed ID: 8153877
[TBL] [Abstract][Full Text] [Related]
4. Mu opioid receptor coupling to Gi/o proteins increases during postnatal development in rat brain.
Talbot JN; Happe HK; Murrin LC
J Pharmacol Exp Ther; 2005 Aug; 314(2):596-602. PubMed ID: 15860573
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
Martin TJ; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1993 Oct; 267(1):506-14. PubMed ID: 8229781
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
Neilan CL; Janvey AJ; Bolan E; Berezowska I; Nguyen TM; Schiller PW; Pasternak GW
J Pharmacol Exp Ther; 2003 Aug; 306(2):430-6. PubMed ID: 12663687
[TBL] [Abstract][Full Text] [Related]
7. Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain.
Titeler M; Lyon RA; Kuhar MJ; Frost JF; Dannals RF; Leonhardt S; Bullock A; Rydelek LT; Price DL; Struble RG
Eur J Pharmacol; 1989 Aug; 167(2):221-8. PubMed ID: 2556284
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
[TBL] [Abstract][Full Text] [Related]
9. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
[TBL] [Abstract][Full Text] [Related]
10. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone-induced upregulation of mu opioid receptors on 7315c cell and brain membranes: enhancement of opioid efficacy in inhibiting adenylyl cyclase.
Côté TE; Izenwasser S; Weems HB
J Pharmacol Exp Ther; 1993 Oct; 267(1):238-44. PubMed ID: 8229750
[TBL] [Abstract][Full Text] [Related]
12. Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences.
Bojnik E; Magyar A; Tóth G; Bajusz S; Borsodi A; Benyhe S
Neuroscience; 2009 Jan; 158(2):867-74. PubMed ID: 18977279
[TBL] [Abstract][Full Text] [Related]
13. Characterization and distribution of [3H]ohmefentanyl binding sites in the human brain.
Wang H; Sarrieau A; Pélaprat D; Roques BP; Vanhove A; Kopp N; Chi ZQ; Rostène W
Synapse; 1991 Jul; 8(3):177-84. PubMed ID: 1948668
[TBL] [Abstract][Full Text] [Related]
14. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
Sircar R; Nichtenhauser R; Ieni JR; Zukin SR
J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795
[TBL] [Abstract][Full Text] [Related]
15. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K
Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160
[TBL] [Abstract][Full Text] [Related]
16. A single residue, Lys108, of the delta-opioid receptor prevents the mu-opioid-selective ligand [D-Ala2,N-MePhe4,Gly-ol5]enkephalin from binding to the delta-opioid receptor.
Minami M; Nakagawa T; Seki T; Onogi T; Aoki Y; Katao Y; Katsumata S; Satoh M
Mol Pharmacol; 1996 Nov; 50(5):1413-22. PubMed ID: 8913373
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the cloned human mu opioid receptor.
Raynor K; Kong H; Mestek A; Bye LS; Tian M; Liu J; Yu L; Reisine T
J Pharmacol Exp Ther; 1995 Jan; 272(1):423-8. PubMed ID: 7815359
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
Zernig G; Burke T; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites.
Dardonville C; Fernandez-Fernandez C; Gibbons SL; Ryan GJ; Jagerovic N; Gabilondo AM; Meana JJ; Callado LF
Bioorg Med Chem; 2006 Oct; 14(19):6570-80. PubMed ID: 16797997
[TBL] [Abstract][Full Text] [Related]
20. Mu opioid receptor binding sites in human brain.
Pilapil C; Welner S; Magnan J; Zamir N; Quirion R
NIDA Res Monogr; 1986; 75():319-22. PubMed ID: 2828981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]